Senores Pharma IPO listing today. GMP hints at solid gains on debut

The IPO of Senores Pharmaceuticals saw a strong investor response, with total subscriptions exceeding 93.41 times by the close.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button